Evidence map›Paper›PMID 42746010›Full record

ArticleEJHaem2026

Acute Myeloid Leukaemia Driven by Rare HNRNPH1::ERG Fusion Gene in an Adult, With Distinct Transcripts Detected by RNASeq at Diagnosis and Relapse: A Case Report.

Hannah Al-Yousuf, Pablo Prieto, Robert Baker, Katherine Clesham, Kate Xu, Andrew Wilson, Jiexin Zheng, Rajeev Gupta, Rob Sellar, Jenny O'Nions

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in EJHaem, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Hannah Al-YousufDepartment of Haematology University College London Hospital NHS Foundation Trust London UK.
Pablo PrietoDepartment of Haematology University College London Hospital NHS Foundation Trust London UK.
Robert BakerSpecialist Integrated Haematology Malignant Diagnostic Service Manual Blood Sciences HSL Pathology London UK.
Katherine CleshamDepartment of Haematology University College London Hospital NHS Foundation Trust London UK.
Kate XuDepartment of Haematology University College London Hospital NHS Foundation Trust London UK.
Andrew WilsonDepartment of Haematology University College London Hospital NHS Foundation Trust London UK.
Jiexin ZhengDepartment of Haematology University College London Hospital NHS Foundation Trust London UK.
Rajeev GuptaDepartment of Haematology University College London Hospital NHS Foundation Trust London UK.
Rob SellarDepartment of Haematology University College London Hospital NHS Foundation Trust London UK.
Jenny O'NionsDepartment of Haematology University College London Hospital NHS Foundation Trust London UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Acute myeloid leukaemia (AML) cases with rare fusion genes, such as ERG-related fusions, constitute less than 1% of AML. They often present with a normal karyotype by conventional cytogenetics but are increasingly detected by RNA sequencing (RNAseq), although their characteristics and the utility of fusion genes as an MRD marker are poorly defined. We report a case of a 19-year-old female presenting with Trial Registration: The authors have confirmed clinical trial registration is not needed for this submission.

Indexed as

fusion genefusion transcriptleukaemiamyeloidmyeloid leukaemia

Identifiers

PMID42746010
PMCPMC13575624

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.